Lung Cancer

1

Editorial Board

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 28 KB

english, 2006

2

Does high intake of fruit and vegetables improve lung cancer survival?

Skuladottir, Halla, Tjoenneland, Anne, Overvad, Kim, Stripp, Connie, Olsen, Jørgen H.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 149 KB

english, 2006

4

10.1016/j.lungcan.2005.10.005

Khan, Sarah

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

5

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

Yoshimura, Naruo, Kudoh, Shinzoh, Kimura, Tatsuo, Mitsuoka, Shigeki, Matsuura, Kuniomi, Hirata, Kazuto, Matsui, Kaoru, Negoro, Shunichi, Nakagawa, Kazuhiko, Fukuoka, Masahiro

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 149 KB

english, 2006

6

Erlotinib in patient with non-small cell lung cancer: Significant symptomatic improvement within a few days but without change in chest X-ray

Garfield, D., Kashef, G.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

7

PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression

Lee, Sung Yong, Hur, Gyu Young, Jung, Ki Hwan, Jung, Hye Cheol, Lee, Sang Yeub, Kim, Je Hyeong, Shin, Chol, Shim, Jae Jeong, In, Kwang Ho, Kang, Kyung Ho, Yoo, Se Hwa

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 192 KB

english, 2006

8

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study

Westeel, V., Breton, J.L., Braun, D., Quoix, E., Milleron, B., Debieuvre, D., Jacoulet, P., Germa, C., Kayitalire, L., Depierre, A.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 136 KB

english, 2006

9

COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals

Han, ShouWei, Roman, Jesse

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 528 KB

english, 2006

10

Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC)

Katakura, Hiromichi, Takenaka, Kazumasa, Nakagawa, Masatsugu, Sonobe, Makoto, Adachi, Masashi, Ito, Shinya, Wada, Hiromi, Tanaka, Fumihiro

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 144 KB

english, 2006

11

Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer

Paul, I., Lappin, T.R.J., Maxwell, P., Graham, A.N.J.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 247 KB

english, 2006

12

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Giorgio, Carmelo Giannitto, Pappalardo, Alessandro, Russo, Antonio, Giuffrida, Dario, Santini, Daniele, Petralia, Giuseppina, Castorina, Sergio, Nunzio, Restuccia, Failla, Giuseppe, Bordonaro, Roberto

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 95 KB

english, 2006

13

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis

Borget, Isabelle, Tilleul, Patrick, Baud, Mariette, Joly, Anne Christine, Daguenel, Anne, Chouaid, Christos

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 132 KB

english, 2006

14

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients

Gautschi, Oliver, Hugli, Barbara, Ziegler, Annemarie, Bigosch, Colette, Bowers, Naomi L., Ratschiller, Daniel, Jermann, Monika, Stahel, Rolf A., Heighway, Jim, Betticher, Daniel C.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 163 KB

english, 2006

15

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

Pujol, Jean-Louis, Barlesi, Fabrice, Daurès, Jean-Pierre

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 163 KB

english, 2006

16

Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer

Leinonen, Tero, Pirinen, Risto, Böhm, Jan, Johansson, Risto, Ropponen, Kirsi, Kosma, Veli-Matti

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 363 KB

english, 2006

17

Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer

Nandan, Raghu

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 56 KB

english, 2006

18

Nitric oxide synthases are associated with bronchial dysplasia

Puhakka, Airi R.A., Harju, Terttu H., Pääkkö, Paavo K., Soini, Ylermi M., Kinnula, Vuokko L.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 207 KB

english, 2006

19

Targeting colloidal particulates to thoracic lymph nodes

Liu, Jiang, Wong, Ho-Lun, Moselhy, Jim, Bowen, Barry, Wu, Xiao Yu, Johnston, Michael R.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 744 KB

english, 2006

Volume 51; Issue 3

Editorial Board

Contents

Does high intake of fruit and vegetables improve lung cancer survival?

10.1016/j.lungcan.2005.10.005

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

Erlotinib in patient with non-small cell lung cancer: Significant symptomatic improvement within a few days but without change in chest X-ray

PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study

COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals

Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC)

Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer

Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer

Nitric oxide synthases are associated with bronchial dysplasia

Targeting colloidal particulates to thoracic lymph nodes